144 16. Amsel A, Wong P, Traupmann K. Short-term and long-term factors in extinction and durable persistence. Journal of Experimental Psychology. 1971;90(1):90-95. 17. Weiner I, Bercovitz H, Lubow RE, Feldon J. The abolition of the partial reinforcement extinction effect (PREE) by amphetamine. Psychopharmacology. 1985;86(3):318-323. doi:10.1007/BF00432221 18. Hofmann W, De Houwer J, Perugini M, Baeyens F, Crombez G. Evaluative conditioning in humans: A meta-analysis. Psychological Bulletin. 2010;136(3):390-421. doi:10.1037/a0018916 19. Kerkhof I, Vansteenwegen D, Baeyens F, Hermans D. Counterconditioning: An effective technique for changing conditioned preferences. Experimental Psychology. 2011;58(1):31-38. doi:10.1027/1618-3169/a000063 20. Meulders A, Karsdorp PA, Claes N, Vlaeyen JWS. Comparing Counterconditioning and Extinction as Methods to Reduce Fear of Movement-Related Pain. The Journal of Pain. 2015;16(12):1353-1365. doi:10.1016/j.jpain.2015.09.007 21. Bartels DJP, van Laarhoven AIM, Stroo M, et al. Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans. Darragh M, ed. PLOS ONE. 2017;12(9):e0182959. doi:10.1371/journal.pone.0182959 22. Faul F, Erdfelder E, Lang AG. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007;39(2):175-191. doi:10.3758/BF03193146 23. Aslaksen PM, Lyby PS. Fear of pain potentiates nocebo hyperalgesia. Journal of pain research. 2015;8:703-710. doi:10.2147/JPR.S91923 24. Colagiuri B, Quinn VF. Autonomic Arousal as a Mechanism of the Persistence of Nocebo Hyperalgesia. The journal of pain : official journal of the American Pain Society. 2018;19(5):476-486. doi:10.1016/j.jpain.2017.12.006 25. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain. 2010;151(2):430-439. doi:10.1016/j.pain.2010.08.007 26. Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. European Journal of Pain. 2006;10(1):77-88. doi:10.1016/J.EJPAIN.2005.02.003 27. Spielberger C, Gorsuch R, Lushene P, Vagg P, Jacobs A. Manual for the StateTrait Anxiety Inventory STAI (Form Y) (“Self-Evaluation Questionnaire”). In: Man StateTrait Anxiety Invent STAI. Consulting Psychologists Press, Inc.; 1983:4-6. 28. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). British Journal of Clinical Psychology. 1992;31(3):301-306. doi:10.1111/j.2044-8260.1992.tb00997.x 29. Sullivan, M.J.L., Bishop, S.R., Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychological Assessment. 1995;7(4):524-532. 30. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. Journal of personality and social psychology. 1994;67(6):1063-1078. doi:10.1037//0022-3514.67.6.1063 31. Bartels DJP, van Laarhoven AIM, Haverkamp EA, et al. Role of Conditioning and Verbal Suggestion in Placebo and Nocebo Effects on Itch. Sakakibara M, ed. PLoS ONE. 2014;9(3):e91727. doi:10.1371/journal.pone.0091727 32. Richardson JTE. Eta squared and partial eta squared as measures of effect size in educational research. Educational Research Review. 2011;6(2):135-147. doi:10.1016/j.edurev.2010.12.001
RkJQdWJsaXNoZXIy MTk4NDMw